Clinical trial
The Ability Of MRI To Detect Adverse Local Tissue Reaction And Implant Integration As A Function Of Hip Implant Modularity
NCT02255331 is registered in ClinicalTrials.gov with Hospital for Special Surgery, New York as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Ability Of MRI To Detect Adverse Local Tissue Reaction And Implant Integration As A Function Of Hip Implant Modularity
- Lead sponsor
- Hospital for Special Surgery, New York
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 15, 2017
- Completion date
- November 1, 2024
- Enrollment
- 587 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
complications; arthroplasty, complications; arthroplasty, mechanical